Skip to main content

Best Momentum Stock to Buy for January 21st

Zacks Investment Research - Wed Jan 21, 5:18AM CST
Best Momentum Stock to Buy for January 21st

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 21st:

Lam Research LRCX: This company, which is a supplier of wafer fabrication equipment and services to the semiconductor industry, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.

Lam Research's shares gained 57.7% over the last three month compared with the S&P 500’s gain of 1.4%. The company possesses a Momentum Score of A.

BNP Paribas BNPQY: This company, which is a European leader in global banking and financial services, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current yearearnings increasing 1.9% over the last 60 days.

BNP Paribas’ shares gained 27.7% over the last three month compared with the S&P 500’s gain of 1.4%. The company possesses a Momentum Score of A.

L'Oreal LRLCY: This company, which made cosmetics the focus of all their energy and know-how for nearly a century, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current yearearnings increasing 1.9% over the last 60 days.

L'Oreal SA Price and Consensus

L'Oreal SA Price and Consensus

L'Oreal SA price-consensus-chart | L'Oreal SA Quote

L'Oreal’s shares gained 4.5% over the last three month compared with the S&P 500’s gain of 1.4%. The company possesses a Momentum Score of B.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Zacks' Research Chief Picks Stock Most Likely to "At Least Double"

Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.

See Our Top Stock to Double (Plus 4 Runners Up) >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Lam Research Corporation (LRCX): Free Stock Analysis Report
 
BNP Paribas SA (BNPQY): Free Stock Analysis Report
 
L'Oreal SA (LRLCY): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.